NCT07308678

AQUACEL® Ag+ Extra™ vs Cutimed® Sorbact®

Wound Closure in Venous Leg Ulcers (VLUs) Treated With AQUACEL® Ag+ Extra™ vs Cutimed® Sorbact®: A Blinded Re-Assessment of Randomized Controlled Trial Findings

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 105 (actual)
• Sponsor: ConvaTec Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Study is to provide a blinded assessment of wound closure status utilizing photographs collected as per standard of care (SOC) during the AAA RCT (WC-22-435).

Detailed description

The purpose of the study is to provide a blinded (treatment arm, timepoint) assessment of wound closure status utilizing photographs collected as per standard of care (SOC) during the AAA Randomized Controlled Trial (RCT) (WC-22-435).

Conditions

• Venous Leg Ulcer
• Diabetic Foot

Timeline

• Start date: 2025-04-22
• Primary completion: 2025-05-28
• Completion: 2025-05-28
• First posted: 2025-12-30
• Last updated: 2026-01-08

Locations

1 site across 1 country: Germany